Cart
0
Get 20% Free Customization In This Report
Buy this report from - $4176

Interventional Cardiology and Peripheral Vascular Devices Market by Product (Angioplasty Balloons, Angioplasty Stents, Angioplasty Catheters, Endovascular Aneurysm Repair Stent Grafts, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Accessories) - Global Opportunity Analysis and Industry Forecast, 2014-2022

LI_161072
Pages: 130
Oct 2016 | 2313 Views
face gplus_n
Author's : Deepa Tatkare
Tables: 48
Charts: 65
twit_n pr_n

Interventional Cardiology and Peripheral Vascular Devices Market Overview :

Interventional Cardiology and Peripheral Vascular Devices Market is expected to garner $25,349 million by 2022, registering a CAGR of 9.7% during the forecast period 2016-2022. Interventional cardiology deals with catheter-based technologies for the treatment of structural heart diseases. The procedure involves the insertion of a device (may be a catheter, balloon, stent, or other devices) into the femoral artery or any large peripheral artery or vein, and cannulating the heart under X-ray visualization (commonly known as fluoroscopy). In addition, numerous interventional devices are used to treat peripheral vascular disorders that affect the circulatory system, and may lead to plaque built-up in the arteries of limbs. Some of the interventional devices used in the market include balloons, catheters, guidewires, stents, and filters.

The Interventional cardiology and peripheral vascular devices makes changes in lifestyle, which leads to cardiovascular disorders, growth in geriatric population, increase in prevalence of chronic diseases, technological advancements in cardiology devices, improvement of healthcare infrastructure in developing countries, development of minimally invasive procedures, and increase in patient awareness drive the market. However, stringent approval process for interventional cardiology & peripheral vascular devices & high treatment cost of some devices (such as stents and drug eluting balloons) have restricted the market growth.

Interventional Cardiology & Peripheral Vascular Devices Market Segmentation

Interventional Cardiology & Peripheral Vascular Devices Market Segmentation

Segment Review:

According to the analysis carried out for each segment, the angioplasty stent systems accounted for the largest market share in 2015. This is mainly due to technological innovations, which have led to the development of bio-engineered stents, EPC capture stents, and dual therapy stents. In addition, stents have more advantage when compared to balloon catheters as they do not leave even a slight chance of plaque build-up or vessel collapse. Hence, ballooning is generally followed by a stent implant to ensure permanent relief.

Interventional Cardiology & Peripheral Vascular Devices Market By Product, 2015, (%)

Interventional Cardiology & Peripheral Vascular Devices Market By Product 2015

India Interventional Cardiology & Peripheral Vascular Devices Market Snapshot:

With ageing population and changes in lifestyle, the prevalence of chronic diseases is rapidly increasing in India. According to National Institutes of Health, in 2010, the occurrence of heart failure in India due to obesity, coronary heart disease, diabetes, hypertension, and rheumatic heart diseases was estimated to range from 1.3 million to 4.6 million with the annual incidence rate of 0.5 million to 1.8 million. In addition, the affordability of the population is increasing with increase in insurance policies, which would further strengthen market growth. Therefore, India is a lucrative market for interventional cardiology & peripheral vascular devices.

India: Interventional Cardiology & Peripheral Vascular Devices, 2014 - 2022 ($Million)

India Interventional Cardiology & Peripheral Vascular Devices 2014-2022

Top Impacting Factors

Top Impacting Factors Interventional Cardiology & Peripheral Vascular Devices Market

Top Impacting Factors Interventional Cardiology & Peripheral Vascular Devices Market

Growing geriatric population and increasing prevalence of diseases

Rise in prevalence of chronic diseases along with rapid increase in geriatric population, worldwide, is set to increase the demand for interventional cardiology and peripheral vascular devices market. According to the American Heart Association, around 70.2% of men and 70.9% of women in the age group of 60‐79 years had cardiovascular disorders in the U.S, in 2013. Moreover, it has been predicted by World Health Organization that there will be an increase of 50% in cardiovascular disorders cases in China between 2010 and 2030 due to increase in geriatric population. Thus, increase in geriatric population and growing prevalence of chronic diseases and lifestyle changes are expected to drive the global market.

Development of minimally invasive procedures

The fear and reluctance in patients for surgeries decreases as surgeons prefer minimally invasive techniques over open surgeries. Minimally invasive techniques limit the size of incisions, reduces the time of wound healing, pain, and risk of infection. Therefore, these are preferred by patients as well as surgeons which in turn propels market growth.

Technological advancements

Continuous technological innovations in the field of interventional cardiology and peripheral vascular devices are expected to drive the global market. Scientists have focused on developing new systems with improved attributes such as new generation of drug eluting balloons, and bioabsorbable stents. In addition to this, several companies have invested in their R&D activities to develop innovative products.

Increasing patient awareness

Awareness among patients about coronary heart diseases and peripheral vascular disorders plays a vital role in market growth. Several educational, government and non-governmental organizations, and key players have launched awareness programs to increase the awareness level about the treatment of these diseases among patients, doctors, and healthcare providers. The impact of this factor currently influences the market growth in the emerging economies, as the adoption of the advanced treatment devices is low in the developing nations.

Improving healthcare infrastructure in developing countries

Over the past decade, governments of various countries, especially emerging economies, have increased their expenditure on developing their healthcare infrastructure. Thus, increase in public and private expenditure to develop the health infrastructure in these regions will further boost the adoption of interventional cardiology and peripheral vascular devices in developing countries.

Stringent approval process

The approval processes in most counties are stringent for interventional cardiology & peripheral vascular devices, as these are highly specialized devices that are introduced in the body.

High treatment cost

The cost of stents increases with advancements in technology. For instance, drug-eluting stents are more expensive as compared to bare metal stents. In addition to this, this list price of bioabsorbable stents is twice as much as the cost of drug-eluting stents and the cost of drug-coated balloons is also high when compared to other interventional cardiology and peripheral vascular devices. This is a major restraint in the developing countries, where majority of the population does not have health insurance.

The key players that operate in the market include Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc., Cook Medical, Inc., Medtronic plc, St. Jude Medical, Inc., Terumo Corporation, and The Spectranetics Corporation.

Other market players in value chain includes, Edwards Lifesciences Corporation, ABIOMED, Inc., AngioDynamics, Inc., Becton, Dickinson & Co., Lepu Medical Technology (Beijing) Co. Ltd., Baxter International Inc., Siemens AG, 3M Company, Biotronik SE & Co. KG, Smith & Nephew plc, Sahajananad Medical Technologies Ltd., HeartWare International, Inc.

Interventional Cardiology & Peripheral Vascular Devices Market Key Benefits:

  • The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.

  • The report provides a quantitative analysis for the period of 2014‐2022 to enable stakeholders to capitalize on the prevailing market opportunities.

  • Extensive analysis of the market based on product helps understand the type of devices used to treat blockages associated with chronic diseases.

  • Competitive intelligence highlights the business practices followed by leading players across various regions.

  • Comprehensive analysis of all geographic regions helps determine the prevailing opportunities in these regions.

  • Key market players and their strategies are analyzed to understand the competitive outlook of the global market.

  • Extensive analysis of the market is conducted by following key product positioning and monitoring the top contenders within the market framework.

Interventional Cardiology & Peripheral Vascular Devices Market Key Segments

By Product

  • Angioplasty Balloons

    • Old/Normal Balloons

    • Cutting and Scoring Balloons

    • Drug-eluting Balloons

  • Angioplasty Stents

    • Drug-eluting Stents

    • Bare Metal Stents

    • Bioabsorbable Stents

  • Angioplasty Catheters

    • Angiography Catheters

    • Guiding Catheters

  • Endovascular Aneurysm Repair Stent Grafts

    • Abdominal Aortic Aneurysm

    • Thoracic Aortic Aneurysm

  • Inferior Vena Cava (IVC) Filters

    • Retrievable Filters

    • Permanent Filters

  • Plaque Modification Devices

    • Thrombectomy Devices

    • Atherectomy Devices

  • Hemodynamic Flow Alteration Devices

    • Embolic Protection Devices

    • Chronic Total Occlusion Devices

  • Accessories

    • Vascular Closure Devices

    • Introducer Sheaths

    • Guidewires

    • Balloon Inflation Devices

By Geography

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe

  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • Malaysia

    • Rest of Asia-Pacific

  • LAMEA

    • Brazil

    • South Africa

    • Egypt

    • Rest of LAMEA

 

Chapter: 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Key players
1.5 Research methodology

1.5.1 Secondary research
1.5.2 Primary research
1.5.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO perspective

Chapter: 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.2.2.1 Competitive intelligence of companies and their strategies

3.3 Market share analysis, 2015
3.4 Market dynamics

3.4.1 Drivers

3.4.1.1 Growing geriatric population and increasing prevalence of chronic diseases
3.4.1.2 Technological advancements
3.4.1.3 Improving healthcare infrastructure in developing countries
3.4.1.4 Development of minimally invasive procedures
3.4.1.5 Increasing patient awareness

3.4.2 Restraints

3.4.2.1 High treatment cost
3.4.2.2 Stringent approval process for interventional cardiology and peripheral vascular devices

3.4.3 Opportunities

3.4.3.1 Huge market opportunities in developing countries
3.4.3.2 Development of Bioabsorbable stents

3.5 Clinical Trials

Chapter: 4 WORLD INTERVENTIONAL CARDIOLGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT

4.1 Overview

4.1.1 Market size and forecast

4.2 Angioplasty Balloons

4.2.1 Old/Normal balloons
4.2.2 Cutting and scoring balloons
4.2.3 Drug eluting balloons
4.2.4 Key market trends
4.2.5 Key growth factors and opportunities
4.2.6 Market size and forecast

4.3 Angioplasty Stents

4.3.1 Coronary stents

4.3.1.1 Bare-metal stents
4.3.1.2 Drug-eluting stents (DES)
4.3.1.3 Bioabsorbable stents

4.3.2 Peripheral stents
4.3.3 Key market trends
4.3.4 Key growth factors and opportunities
4.3.5 Market size and forecast

4.4 Angioplasty Catheters

4.4.1 Angiography Catheters
4.4.2 Guiding Catheters
4.4.3 Key market trends
4.4.4 Key growth factors and opportunities
4.4.5 Market size and forecast

4.5 Endovascular Aneurysm Repair Stent Grafts

4.5.1 Abdominal aortic aneurysm
4.5.2 Thoracic aortic aneurysm
4.5.3 Key market trends
4.5.4 Key growth factors and opportunities
4.5.5 Market size and forecast

4.6 Inferior Vena Cava (IVC) Filters

4.6.1 Permanent filters
4.6.2 Retrievable filters
4.6.3 Key market trends
4.6.4 Key growth factors and opportunities
4.6.5 Market size and forecast

4.7 Plaque Modification Devices

4.7.1 Thrombectomy devices
4.7.2 Atherectomy devices
4.7.3 Key market trends
4.7.4 Key growth factors and opportunities
4.7.5 Market size and forecast

4.8 Hemodynamic Flow Alteration Devices

4.8.1 Embolic protection devices
4.8.2 Chronic total occlusion devices
4.8.3 Key market trends
4.8.4 Key growth factors and opportunities
4.8.5 Market size and forecast

4.9 Accessories

4.9.1 Vascular closure devices
4.9.2 Introducer sheaths
4.9.3 Guidewires
4.9.4 Balloon inflation devices
4.9.5 Key market trends
4.9.6 Key growth factors and opportunities
4.9.7 Market size and forecast

Chapter: 5 WORLD INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY GEOGRAPHY, 2014-2022

5.1 Overview

5.1.1 Market size and forecast

5.2 North America

5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.2.4 U.S. market size and forecast
5.2.5 Canada market size and forecast
5.2.6 Mexico market size and forecast

5.3 Europe

5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast
5.3.4 Germany market size and forecast
5.3.5 France market size and forecast
5.3.6 U.K. market size and forecast
5.3.7 Italy market size and forecast
5.3.8 Spain market size and forecast
5.3.9 Rest of Europe market size and forecast

5.4 Asia-Pacific

5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast
5.4.4 Japan market size and forecast
5.4.5 China market size and forecast
5.4.6 India market size and forecast
5.4.7 Malaysia market size and forecast
5.4.8 Australia market size and forecast
5.4.9 Rest of Asia-Pacific market size and forecast

5.5 LAMEA

5.5.1 Key market trends
5.5.2 Key growth factors and opportunities
5.5.3 Market size and forecast
5.5.4 Brazil market size and forecast
5.5.5 South Africa market size and forecast
5.5.6 Egypt market size and forecast
5.5.7 Rest of LAMEA market size and forecast

Chapter: 6 COMPANY PROFILES

6.1 Abbott Laboratories

6.1.1 Company Overview
6.1.2 Company Snapshot
6.1.3 Operating Business Segments
6.1.4 Business Performance
6.1.5 Key Strategic Moves & Developments

6.2 B. Braun Melsungen AG

6.2.1 Company Overview
6.2.2 Company Snapshot
6.2.3 Operating Business Segments
6.2.4 Business Performance
6.2.5 Key Strategic Moves & Developments

6.3 Boston Scientific Corporation

6.3.1 Company Overview
6.3.2 Company Snapshot
6.3.3 Operating Business Segments
6.3.4 Business Performance
6.3.5 Key Strategic Moves & Developments

6.4 C. R. Bard, Inc.

6.4.1 Company Overview
6.4.2 Company Snapshot
6.4.3 Operating Business Segments
6.4.4 Business Performance
6.4.5 Key Strategic Moves & Developments

6.5 Cardinal Health, Inc.

6.5.1 Company Overview
6.5.2 Company Snapshot
6.5.3 Operating Business Segments
6.5.4 Business Performance
6.5.5 Key Strategic Moves & Developments

6.6 Cook Medical, Inc.

6.6.1 Company Overview
6.6.2 Company Snapshot
6.6.3 Operating Business Segments
6.6.4 Key Strategic Moves & Developments

6.7 Medtronic plc

6.7.1 Company Overview
6.7.2 Company Snapshot
6.7.3 Operating Business Segments
6.7.4 Business Performance
6.7.5 Key Strategic Moves & Developments

6.8 St. Jude Medical, Inc.

6.8.1 Company Overview
6.8.2 Company Snapshot
6.8.3 Operating Business Segments
6.8.4 Business Performance
6.8.5 Key Strategic Moves & Developments

6.9 Terumo Corporation

6.9.1 Company Overview
6.9.2 Company Snapshot
6.9.3 Operating Business Segments
6.9.4 Business Performance
6.9.5 Key Strategic Moves & Developments

6.10 The Spectranetics Corporation

6.10.1 Company Overview
6.10.2 Company Snapshot
6.10.3 Operating Business Segments
6.10.4 Business Performance
6.10.5 Key Strategic Moves & Developments

List of Charts

FIG. 1 WORLD INTERVENTIONAL CRDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2015 VS 2022, ($MILLION)
FIG. 2 INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET SEGMENTATION
FIG. 3 TOP INVESTMENT POCKETS
FIG. 4 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIG. 5 TOP WINNING STRATEGIES: NATURE AND TYPE
FIG. 6 TOP COMPANIES AND THEIR STRATEGIES
FIG. 7 DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIG. 8 DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIG. 9 MARKET SHARE ANALYSIS, 2015
FIG. 10 TOP IMPACTING FACTORS: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET
FIG. 11 CLINICAL TRIALS IN WORLD INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET
FIG. 12 CLINICAL TRIALS FOR INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES, (%)
FIG. 13 WORLD PERIPHERAL STENTS MARKET, BY TYPE, 2014-2022 ($MILLION)
FIG. 14 U.S. INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 15 CANADA INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 16 MEXICO INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 17 GERMANY INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 18 FRANCE INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 19 U.K. INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 20 ITALY INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 21 SPAIN INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 22 REST OF EUROPE INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 23 JAPAN INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 24 CHINA INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 25 INDIA INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 26 MALAYSIA INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 27 AUSTRALIA INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 28 REST OF ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 29 BRAZIL INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 30 SOUTH AFRICA INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 31 EGYPT INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 32 REST OF LAMEA INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 33 ABBOTT: NET SALES, 2013-2015 ($MILLION)
FIG. 34 ABBOTT: NET SALES, BY SEGMENT, 2015 (%)
FIG. 35 ABBOTT: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 36 ABBOTT: STRATEGY SHARE, (%)
FIG. 37 B. BRAUN: NET SALES, 2013-2015 ($MILLION)
FIG. 38 B. BRAUN: NET SALES, BY SEGMENT, 2015 (%)
FIG. 39 B. BRAUN: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 40 BOSTON SCIENTIFIC: NET SALES, 2013-2015 ($MILLION)
FIG. 41 BOSTON SCIENTIFIC: NET SALES, BY SEGMENT, 2015 (%)
FIG. 42 BOSTON SCIENTIFIC: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 43 BOSTON SCIENTIFIC: STRATEGY SHARE, (%)
FIG. 44 BARD: NET SALES, 2013-2015 ($MILLION)
FIG. 45 BARD: NET SALES, BY SEGMENT, 2015 (%)
FIG. 46 BARD: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 47 CARDINAL HEALTH: NET SALES, 2014-2016 ($MILLION)
FIG. 48 CARDINAL HEALTH: NET SALES, BY SEGMENT, 2016 (%)
FIG. 49 CARDINAL HEALTH: NET SALES, BY GEOGRAPHY, 2016 (%)
FIG. 50 MEDTRONIC: NET SALES, 2014-2016 ($MILLION)
FIG. 51 MEDTRONIC: NET SALES, BY SEGMENT, 2016 (%)
FIG. 52 MEDTRONIC: NET SALES, BY GEOGRAPHY, 2016 (%)
FIG. 53 MEDTRONIC: STRATEGY SHARE, (%)
FIG. 54 ST. JUDE MEDICAL: NET SALES, 2013-2015 ($MILLION)
FIG. 55 ST. JUDE MEDICAL: NET SALES, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
FIG. 56 ST. JUDE MEDICAL: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 57 ST. JUDE MEDICAL: STRATEGY SHARE, (%)
FIG. 58 TERUMO: NET SALES, 2014-2016 ($MILLION)
FIG. 59 TERUMO: NET SALES, BY SEGMENT, 2016 (%)
FIG. 60 TERUMO: NET SALES, BY GEOGRAPHY, 2016 (%)
FIG. 61 TERUMO: STRATEGY SHARE, (%)
FIG. 62 SPECTRANETICS: NET SALES, 2013-2015 ($MILLION)
FIG. 63 SPECTRANETICS: NET SALES, BY SEGMENT, 2015 (%)
FIG. 64 SPECTRANETICS: NET SALES, BY PRODUCT LINE, 2015 (%)
FIG. 65 SPECTRANETICS: STRATEGY SHARE, (%)

List of Tables

TABLE 1 WORLD INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 2 WORLD ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 3 ANGIOPLASTY BALLOONS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 4 WORLD ANGIOPLASTY STENTS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 5 WORLD CORONARY STENTS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 6 ANGIOPLASTY STENTS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 7 WORLD ANGIOPLASTY CATHETERS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 8 ANGIOPLASTY CATHETERS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 9 WORLD ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 10 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 11 TYPES OF IVC FILTERS AVAILABLE IN THE MARKET
TABLE 12 WORLD INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 13 INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 14 WORLD PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 15 PLAQUE MODIFICATION DEVICES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 16 WORLD HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 17 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 18 WORLD ACCESSORIES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 19 ACCESSORIES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 20 INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 21 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 22 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 23 EUROPE: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 24 EUROPE: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 25 ASIA-PACIFIC: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 26 ASIA-PACIFIC: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 27 LAMEA: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 28 LAMEA: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 29 ABBOTT: COMPANY SNAPSHOT
TABLE 30 ABBOTT: OPERATING SEGMENTS
TABLE 31 B. BRAUN: COMPANY SNAPSHOT
TABLE 32 B. BRAUN: OPERATING SEGMENTS
TABLE 33 BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 34 BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 35 BARD: COMPANY SNAPSHOT
TABLE 36 BARD: OPERATING SEGMENTS
TABLE 37 CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 38 CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 39 COOK MEDICAL: COMPANY SNAPSHOT
TABLE 40 COOK MEDICAL: DIVISIONS
TABLE 41 MEDTRONIC: COMPANY SNAPSHOT
TABLE 42 MEDTRONIC: OPERATING SEGMENTS
TABLE 43 ST. JUDE MEDICAL: COMPANY SNAPSHOT
TABLE 44 ST. JUDE MEDICAL: PRODUCT CATEGORIES
TABLE 45 TERUMO: COMPANY SNAPSHOT
TABLE 46 TERUMO: OPERATING SEGMENTS
TABLE 47 SPECTRANETICS: COMPANY SNAPSHOT
TABLE 48 SPECTRANETICS: OPERATING SEGMENTS

 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry

Request sample

OR

Purchase Full Report of
Interventional Cardiology and Peripheral Vascular Devices Market- Global Opportunity Analysis and Industry Forecast, 2014-2022

  • Online Only
  • $4176
  • Online cloud Access only
  • Restected Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4640
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5540
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6654
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprice
    License/PDF

  • $9280
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  • Free quartery industry update
  • Free report update (Within 180 days)
  • Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo